ARYA Sciences Acquisition Corp V Class A (ARYE)
$10.36
$0.00 (0.00%)As on 21-Jul-2023 09:30EDT
Market cap
$199 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
69.1
P/B Ratio
1.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.5
-
Face value
--
-
Shares outstanding
15,449,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ARYA Sciencescquisition Corp V Class A (ARYE)
| 2.7 | 0.0 | 1.1 | 6.4 | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
Company
|
2022
|
|---|---|
|
ARYA Sciencescquisition Corp V Class A (ARYE)
| 4.0 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ARYA Sciencescquisition Corp V Class A (ARYE)
|
10.4 | 198.8 | 0.0 | 2.0 | -- | 1.4 | 69.1 | 1.3 |
| 10.1 | 295.9 | 0.0 | -7.4 | -- | -- | -- | 4.2 |
Shareholding Pattern
View DetailsAbout ARYA Sciencescquisition Corp V Class A (ARYE)
ARYA Sciences Acquisition Corp V does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or... healthcare-related industries. The company was incorporated in 2021 and is based in New York, New York. Read more
-
CEO & Director
Mr. Adam Leo Stone
-
CEO & Director
Mr. Adam Leo Stone
-
Headquarters
New York, NY
-
Website
--
FAQs for ARYA Sciencescquisition Corp V Class A (ARYE)
What is the current share price of ARYA Sciences Acquisition Corp V Class A (ARYE) Today?
The share price of ARYA Sciences Acquisition Corp V Class A (ARYE) is $10.36 (NASDAQ) as of 21-Jul-2023 09:30 EDT. ARYA Sciences Acquisition Corp V Class A (ARYE) has given a return of 6.37% in the last 1 years.
What is the current PB & PE ratio of ARYA Sciences Acquisition Corp V Class A (ARYE)?
The P/E ratio of ARYA Sciences Acquisition Corp V Class A (ARYE) is 69.07 times as on 21-Jul-2023.
The P/B ratio of ARYA Sciences Acquisition Corp V Class A (ARYE) is 1.31 times as on 21-Jul-2023, a 11 discount to its peers’ median range of 1.47 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
12.28 |
0.28 |
2021 |
-13.12 |
0.27 |
2022 |
12.28 |
0.28 |
2021 |
-13.12 |
0.27 |
What is the 52 Week High and Low of ARYA Sciences Acquisition Corp V Class A (ARYE)?
The 52-week high and low of ARYA Sciences Acquisition Corp V Class A (ARYE) are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of ARYA Sciences Acquisition Corp V Class A (ARYE)?
ARYA Sciences Acquisition Corp V Class A (ARYE) has a market capitalisation of $ 199 Mln as on 21-Jul-2023. As per SEBI classification, it is a company.
Should I invest in ARYA Sciences Acquisition Corp V Class A (ARYE)?
Before investing in ARYA Sciences Acquisition Corp V Class A (ARYE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.